To beat China in the lab, America’s edge is trust not speed

The U.S. faces challenges in clinical research as China makes strides, but the real advantage lies in America's focus on trust over speed in drug development. By prioritizing a more reliable and transparent process, the U.S. could set a global standard that others follow, ensuring safety and efficacy. This approach not only addresses immediate competition but also builds a robust framework that could lead to more innovative and trustworthy healthcare solutions worldwide. Ultimately, the emphasis on trust could redefine global clinical research standards, offering long-term benefits that outpace any short-term race to the finish.